CDTX: Nilai perusahaan marang bathi resik Cidara

cidara.com - logo grafis emiten CDTX

What are the growth horizons for Cidara Therapeutics (CDTX) given its high concentration on immunotherapy? The answer is provided by the company's price-to-earnings trend, where -35.50 marks a new level. Current capital is based on grants and partner payments while the company's own profit stream is being established. Strict compliance with environmental standards in the development of antifungal agents completes the business profile.

CDTX - Pangali P/E Cidara Therapeutics Inc ing rentang 04.07.2022 - 17.01.2026

Rincian analitis perusahaan Cidara Therapeutics (CDTX)

- rega lan prakiraan konsensus rega:
Rega saham Cidara Therapeutics Corp|CDTX - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Cidara Therapeutics, Inc.|CDTX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham Cidara|CDTX - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku cidara.com|CDTX - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Cidara Therapeutics|CDTX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal cidara.com|CDTX - Utang perusahaan|Utang-utang marang aset resik Cidara Therapeutics, Inc.|CDTX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cidara|Koefisien jangkoan perantara cidara.com
- statistik bathi lan rasio pasar:
CDTX - Bathi resik|Prakiraan bathi resik Cidara Therapeutics|CDTX - Pangali P/E|Pangali Forward P/E Cidara Therapeutics Inc|CDTX - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Cidara Therapeutics, Inc.|CDTX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Cidara|CDTX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan cidara.com|CDTX - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Cidara Therapeutics
- statistik dodolan lan pendapatan perusahaan:
CDTX - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan Cidara Therapeutics|CDTX - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cidara Therapeutics, Inc.
Analisis komprehensif perusahaan:Cidara Therapeutics
Barang unggulan Cidara Therapeutics

Cidara Therapeutics (CDTX) operates within an autonomous innovative drug development cycle, rendering its business resilient to macroeconomic shocks. By analyzing the company's trailing P/E, an investor assesses the ratio of the stock's market value to net income, determining the degree of overvaluation and the price margin of safety during periods of market volatility.

Pesaing wigati

Pangali P/E gilead.com|Koefisien rega marang bathi NVAX (Novavax)|CVAC (CureVac NV) - Nilai perusahaan marang bathi resik|Valneva Pharma - Koefisien rega marang bathi|Vir Corp - Rasio rega marang bathi|SIGA Technologies, Inc. - Pangali P/E|Periode bali modal bisnis emergentbiosolutions.com EBS|Atea Pharmaceuticals, Inc. (AVIR) - Rasio rega marang bathi|Invivyd - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi ENTA|Pangali P/E Inovio Pharma|Rasio rega marang bathi HilleVax, Inc. (HLVX)|Periode bali modal bisnis kalaristx.com|Pangali P/E DYAI (Dyadic International, Inc.)|NNVC - Koefisien rega marang bathi|Talphera Corp - Pangali P/E|Periode bali modal bisnis Cocrystal Pharma Corp COCP|TRAW: Pangali P/E|Pangali rega marang bathi DWTX|QLGN (Qualigen Therapeutics, Inc.) - Pangali P/E|Pangali P/E AlloVir Bio|Rasio rega marang bathi VBI Vaccines Inc. (VBIV)|VIRI (virios.com) - Nilai perusahaan marang bathi resik|Pangali P/E VXRT (Vaxart)